CD163 and neoplasm: As a result of examining the expressions of six types of macrophage markers (pan-macrophage [CD68, F4/80], M1-type [CD80, CD86], and M2-type [CD163, CD206] macrophage markers), it was revealed that only the expression of the tumor-promotive M2-type marker CD163 was significantly reduced [20].